Foley & Lardner LLP announced today that Karen Mangasarian has joined the firm’s Chemical, Biotechnology & Pharmaceutical Practice as a partner in the New York office.
Mangasarian regularly counsels a diverse group of life sciences clients across a wide range of technology areas, including small molecule pharmaceuticals, pharmaceutical formulations, biologics, diagnostic and therapeutic methods in molecular and cellular biology, immunology, microbiology, biochemistry, genomics and computational biology.
“Karen’s extensive experience handling a variety of intellectual property matters for clients in the life sciences space, paired with her deep background in pharmacology and biochemistry, aligns well with our focus on helping clients maximize the value of, and protect, their technology,” said Kristel Schorr, Chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice.
Mangasarian works closely with her clients to provide patent counseling services, including obtaining international and domestic patent rights, creating competitive patent strategies, strategic planning, licensing and product life cycle management. She also has experience with post-grant procedures, such as interferences, re-examinations, oppositions and litigation.
“Karen brings an exceptional depth of patent counseling knowledge to Foley,” said Peter Wang, Managing Partner of the firm’s New York City office. “Her experience complements our office’s strong Patent Litigation and Trademark, Copyright & Advertising Litigation practices, as well as our robust national patent counseling work. We are delighted to have her join us as an integral part of our team.”
Prior to joining Foley, Mangasarian was a partner at Ropes & Gray LLP.
Mangasarian regularly counsels a diverse group of life sciences clients across a wide range of technology areas, including small molecule pharmaceuticals, pharmaceutical formulations, biologics, diagnostic and therapeutic methods in molecular and cellular biology, immunology, microbiology, biochemistry, genomics and computational biology.
“Karen’s extensive experience handling a variety of intellectual property matters for clients in the life sciences space, paired with her deep background in pharmacology and biochemistry, aligns well with our focus on helping clients maximize the value of, and protect, their technology,” said Kristel Schorr, Chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice.
Mangasarian works closely with her clients to provide patent counseling services, including obtaining international and domestic patent rights, creating competitive patent strategies, strategic planning, licensing and product life cycle management. She also has experience with post-grant procedures, such as interferences, re-examinations, oppositions and litigation.
“Karen brings an exceptional depth of patent counseling knowledge to Foley,” said Peter Wang, Managing Partner of the firm’s New York City office. “Her experience complements our office’s strong Patent Litigation and Trademark, Copyright & Advertising Litigation practices, as well as our robust national patent counseling work. We are delighted to have her join us as an integral part of our team.”
Prior to joining Foley, Mangasarian was a partner at Ropes & Gray LLP.
Related News
01 May 2024
Press Releases
Foley Continues to Grow Its East Coast Transactions Practice, Adds M&A Partner Jeff Symons in New York
Foley & Lardner LLP announced today that it has strengthened its Transactions Practice with the addition of M&A partner Jeff Symons in New York.
30 April 2024
Press Releases
Foley Ventures Announces Fifth Fund to Invest in Firm Clients
Foley Ventures is pleased to announce Foley Ventures V, its latest venture fund launched in April 2024 to invest in companies and debt and equity fund clients.
24 April 2024
Press Releases
Nathaniel Lacktman Joins Tampa Bay Wave’s HealthTech|X Accelerator Advisory Council
Foley & Lardner LLP partner Nathaniel “Nate” Lacktman will serve as a member of the Advisory Council for Tampa Bay Wave’s inaugural HealthTech|X Accelerator program, an innovative initiative to support high-potential health technology startups ready to scale in Tampa and beyond.